KyungYi Kim

KyungYi Kim

Auto-generated profile, based on publicly available information

KyungYi Kim

Department of Biohealth Industry, Graduate School of Transdisciplinary Health Sciences, Yonsei University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MHMinji Hong
Minji Hong
VRVasuki Rajaguru
Vasuki Rajaguru
KKKyungYi Kim
KyungYi Kim
SJSuk-Yong Jang
Suk-Yong Jang
SLSang Gyu Lee
Sang Gyu Lee
Background: Menstruation is a physical symptom that occurs in women of reproductive age. It has a significant impact on the daily life and health of women when their academic and social activities are most active. Since many women experience difficulties in daily life because of premenstrual syndrome and dysmenorrhea, it is important to identify, prepare for, and manage the menstrual cycle in advance. Objective: This study aimed to investigate the relationship between menstruation-related experiences and the use of mobile-based period tracker apps by millennial and generation Z (gen Z) individuals. The objectives of this study are to investigate (1) menstrual cycle management, (2) factors affecting app usage (3) factors affecting cycle management, and (4) motivators and barriers to using period tracker apps, in millennial and gen Z women. Methods: A mixed methods design was used for this study. The participants were young women aged 20-39 years and recruited via the Ovey application. Data were collected through surveys and focus group interviews. The survey was conducted among 700 women, and 8 of them participated in the focus group interviews. Results: In total, 431 (62.3%) participants used period tracker apps primarily to predict their next menstrual cycle. Factors affecting app usage included childbirth experience (odds ratio [OR] 0.475, P<.05), number of dysmenorrhea symptoms (OR 1.136, P<.05), and cycle management level (OR 2.279, P<.001). Additionally, education level (OR 1.122, P<.05 [university level compared high school level]) and the number of dysmenorrhea symptoms (OR 1.024, P<.05) showed a positive association with the cycle management level. However, childbirth experience (OR 0.902, P<.05) and period irregularity (OR 0.929, P<.001) were negatively associated with the cycle management level. Conclusions: Period tracker apps are becoming the new normal among millennials and gen Z individuals for managing their menstrual cycles. The use of a period tracker app empowers women by helping them gain a better understanding of their bodies, ultimately enhancing their social, academic, and health-related lives. Improving the accuracy and literacy of the app is an ongoing task for period-tracking apps, and it is important to provide added value tailored to users’ needs. Therefore, the findings of this study should be considered when designing or upgrading period tracker apps to facilitate the adoption of digital technology among young women, thereby promoting their overall well-being and reproductive health.

1 January 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
KKKyungYi Kim
KyungYi Kim
Tae Hyun KimTae Hyun Kim
Tae Hyun Kim
SLSang Gyu Lee
Sang Gyu Lee
M.M.S.
M.S.
M.M.D.
M.D.
M.M.B.A.
M.B.A.
KyungYi Kim, M.S., Sang-Guk Lee, M.D., Ph.D., Tae Hyun Kim, Ph.D., and Sang Gyu Lee, M.D., Ph.D., M.B.A.. Ann Lab Med 2022;42:89-95. https://doi.org/10.3343/alm.2022.42.1.89

30 September 2023 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
SLSejeong Lee
Sejeong Lee
KKKyungYi Kim
KyungYi Kim
JKJi Eun Kim
Ji Eun Kim
YHYura Hyun
Yura Hyun
MLMinyoung Lee
Minyoung Lee
EKEun Seok Kang
Eun Seok Kang
Background: Given the importance of continuous self-care for people with type 1 diabetes mellitus (T1DM), the Ministry of Health and Welfare of Korea launched a pilot program for chronic disease management. Herein, we applied a home care pilot program to people with T1DM to investigate its effects.Methods: This retrospective cohort study was conducted at a single tertiary hospital (January 2019 to October 2021). A multidisciplinary team comprising doctors, nurses, and clinical nutritionists provided specialized education and periodically assessed patients’ health status through phone calls or text messages. A linear mixed model adjusting for age, sex, and body mass index was used to analyze the glycemic control changes before and after implementing the program between the intervention and control groups.Results: Among 408 people with T1DM, 196 were enrolled in the intervention group and 212 in the control group. The reduction in glycosylated hemoglobin (HbA1c) after the program was significantly greater in the intervention group than in the control group (estimated marginal mean, –0.57% vs. –0.23%, P=0.008); the same trend was confirmed for glycoalbumin (GA) (–3.2% vs. –0.39%, P<0.001). More patients achieved the target values of HbA1c (<7.0%) and GA (<20%) in the intervention group than in the control group at the 9-month follow-up (34.5% vs. 19.6% and 46.7% vs. 28.0%, respectively).Conclusion: The home care program for T1DM was clinically effective in improving glycemic control and may provide an efficient care option for people with T1DM, and positive outcomes are expected to expand the program to include more patients.

1 January 2024 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
KKKyungYi Kim
KyungYi Kim
MHMin Ji Hong
Min Ji Hong
BKBomgyeol Kim
Bomgyeol Kim
HYHan Young Yu
Han Young Yu
Tae Hyun KimTae Hyun Kim
Tae Hyun Kim
Hypertension is a significant risk factor for cardiovascular disease (CVD), with hypertension-related deaths increasing annually. While South Korea uses the Korean Society of Hypertension (KSH) guideline of 140/90 mmHg, the American College of Cardiology (ACC) and American Heart Association (AHA) updated their guidelines in 2017 to 130/80 mmHg. This study evaluates the cost-effectiveness of transitioning to the 2017 ACC/AHA guidelines by estimating early treatment impacts and potential CVD risk reduction. A Markov state-transition simulation model with a 10-year horizon was used to estimate cost-effectiveness, focusing on strengthening target blood pressure. Quality-adjusted life years (QALYs) served as the measure of effectiveness. Cohorts of 10,000 individuals representing South Koreans in their 20s through 80s were compared in scenario analyses from the healthcare system perspective. A 4.5% annual discount rate was applied to costs and effectiveness. Primary outcomes were incremental cost-effectiveness ratio (ICER) and net monetary benefit (NMB). The willingness-to-pay (WTP) threshold was < KRW 30,000,000/QALY gained. Probabilistic sensitivity analyses (PSAs) addressed model input parameter uncertainties. The base-case analysis showed an ICER value of KRW 1,328,395/QALY gained across all populations. ICER values increased with age, from − KRW 3,138,071/QALY for 20-year-olds to KRW 16,613,013/QALY for individuals over 80. The 60s age group showed the greatest benefit with an incremental QALY gain of 0.46. All scenarios had ICERs below the WTP threshold, with a PSA probability of 98.0% that strengthening blood pressure classification could be cost-effective. This economic evaluation found that adopting the 2017 ACC/AHA guidelines may result in early treatment, reduce the potential incidence of CVD events, and be cost-effective across all age groups. The study findings have implications for policymakers deciding whether and when to revise official guidelines regarding target blood pressure levels, considering the impacts on public health and budgetary concerns.

1 May 2025 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
KKKyungYi Kim
KyungYi Kim
HKHyung Woo Kim
Hyung Woo Kim
BKBeom Seok Kim
Beom Seok Kim
SJSuk-Yong Jang
Suk-Yong Jang
JSJaeyong Shin
Jaeyong Shin
SLSang Gyu Lee
Sang Gyu Lee
Background: Digital health technologies have been rapidly adopted during the coronavirus disease 2019 pandemic. In Korea, a home care program, including face-to-face educational consultation and remote patient monitoring, was initiated to improve patients’ quality of life. This study focused on patients with end-stage renal disease undergoing peritoneal dialysis to verify the long-term clinical effectiveness of this home care program. Methods: This retrospective cohort study was designed as a pre–post study to analyze the clinical impact of a home care program for patients undergoing peritoneal dialysis in a single tertiary care hospital. A total of 186 patients were selected from June 2017 to May 2022 to identify clinical changes after program implementation by analyzing changes in peritonitis incidence and laboratory test results. Interrupted time series analyses with ordinary least squares linear regression and chi-square tests were used. Results: At baseline, the incidence of peritonitis continuously increased by 0.480 cases per 1,000 patient-months (p = 0.02). After program initiation, the trend significantly decreased by 0.886 cases per 1,000 patient-months (p = 0.02). In addition, the proportion of individuals reaching the clinical target range had increased calcium levels (4.9%p, p = 0.003), stable hemoglobin (1.2%p, p = 0.477), phosphorus (2.8%p, p = 0.09), potassium (–1.6%p, p = 0.22), while parathyroid hormone levels decreased (–6.6%p, p = 0.005). Conclusion: With a reduction in peritonitis incidence and overall improvement in laboratory test results, our study suggests that conducting a home care program for patients undergoing peritoneal dialysis is clinically effective.

28 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KKKyungYi Kim
KyungYi Kim
JKJunghyun Kim
Junghyun Kim
JSJaeyong Shin
Jaeyong Shin
MKMan Seok Kim
Man Seok Kim
SPSang-Hoon Park
Sang-Hoon Park
SOSinae Oh
Sinae Oh
Artificial intelligence (AI) shows promise in improving the accuracy and efficiency of lung cancer screening, but its economic value remains uncertain. We developed a decision-analytic model combining a decision tree and Markov model to evaluate five screening strategies in South Korea: no screening, chest X-ray (CXR), AI-assisted CXR, low-dose computed tomography (LDCT), and AI-assisted LDCT. We simulated hypothetical cohorts of 10,000 individuals, stratified by age group and smoking status to reflect the Korean population distribution, and projected their lifetime costs and quality-adjusted life years (QALYs). Analyses applied a 4.5% discount rate and a willingness-to-pay (WTP) threshold of $32,409.9 per QALY. AI-assisted CXR produced incremental cost-effectiveness ratio (ICER) of $8679–$10,030 per QALY, demonstrating cost-effectiveness across all age groups. CXR alone was less favorable, and LDCT-based strategies exceeded the willingness-to-pay (WTP) threshold. These findings suggest AI-assisted CXR offers a scalable, economically viable strategy for lung cancer screening, supporting its integration into national programs.